Optimizing Biomarker-Directed Therapy to Advance CRC Care: A Clinical Connections Session
hosted byPrime Education, LLCOptimizing Biomarker-Directed Therapy to Advance CRC Care: A Clinical Connections Session is organized by Prime Education, LLC.
Release Date: November 28, 2023
Expiration Date: November 27, 2024
Description:
Novel and emerging biomarkers are improving outcomes for patients with colorectal cancer (CRC). Tune in for a comprehensive discussion on the latest advances in biomarker-directed therapy for CRC.
During this Clinical Connections webcast, multidisciplinary oncology experts discuss:
• Incorporating biomarker testing into treatment selection and sequencing
• The latest clinical efficacy and safety data of biomarker-driven combination therapies
• Coordinating multidisciplinary care
Learning Objectives:
• Describe the established biomarkers and recommended biomarker tests for patients with colorectal cancer
• Evaluate evolving clinical data on the efficacy, safety, and utility of novel biomarker-driven combination therapies for the treatment of unresectable or • metastatic colorectal cancer
• Apply biomarker testing results to guide treatment selection for patients with unresectable or metastatic colorectal cancer
• Assess potential logistical considerations for the incorporation of comprehensive colorectal cancer biomarker testing into clinical practice
Agenda:
• Established Colorectal Cancer Biomarkers and Recommended Biomarker Testing
• Evolving Clinical Data on the Efficacy, Safety, and Tolerability of Novel Biomarker-Driven Combination Therapies for the Treatment of Patients With Unresectable or Metastatic Colorectal Cancer
• Applying Biomarker Testing Results to Guide Treatment Decisions for Patients With Unresectable or Metastatic Colorectal Cancer
• Incorporating Comprehensive Colorectal Biomarker Testing Into Clinical Practice
. Introduction of the Biomarker Testing Resource
